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Foci of the HIV epidemic and helminthic infections largely overlap geographically. Treat-
ment options for helminth infections are limited, and there is a paucity of drug-development
research in this area. Limited evidence suggests that antiretroviral therapy (ART) reduces
prevalence of helminth infections in HIV-infected individuals. We investigated whether ART
exposure and cotrimoxazole preventive therapy (CTX-P) is associated with a reduced prev-
alence of helminth infections.
Methodology and Principal Findings
This cross-sectional study was conducted at a primary HIV-clinic in Lambaréné, Gabon.
HIV-infected adults who were ART-naïve or exposed to ART for at least 3 months submitted
one blood sample and stool and urine samples on 3 consecutive days. Outcome was hel-
minth infection with intestinal helminths, Schistosoma haematobium, Loa loa orMansonella
perstans. Multivariable logistic regression was used to assess associations between ART
or CTX-P and helminth infection. In total, 408 patients were enrolled. Helminth infection was
common (77/252 [30.5%]). Filarial infections were most prevalent (55/310 [17.7%]), fol-
lowed by infection with intestinal helminths (35/296 [11.8%]) and S. haematobium (19/323
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[5.9%]). Patients on CTX-P had a reduced risk of Loa loamicrofilaremia (adjusted odds
ratio (aOR) 0.47, 95% CI 0.23-0.97, P = 0.04), also in the subgroup of patients on ART
(aOR 0.36, 95% CI 0.13-0.96, P = 0.04). There was no effect of ART exposure on helminth
infection prevalence.
Conclusions/Significance
CTX-P use was associated with a decreased risk of Loa loa infection, suggesting an anthel-
minthic effect of antifolate drugs. No relation between ART use and helminth infections
was established.
Author Summary
The geographical distribution of helminth infections, which are highly prevalent in many
areas, overlaps considerably with regions of high HIV sero-prevalence. The highest burden
of infection is found in resource-poor settings, making it unattractive for the pharmaceuti-
cal industry to invest. Limited available treatment options and drug-resistance are increas-
ing problems for soil-transmitted helminths, whereas for some other helminth infections,
such as for the blood-dwelling microfilariae, effective and safe treatment options are still
far from being optimal. Limited evidence suggests antihelminthic effects of antiretroviral
therapy (ART) in HIV-infected individuals. We aimed to investigate whether ART or
cotrimoxazole preventive treatment (CTX-P) reduces prevalence of helminth infection in
HIV-infected individuals attending a primary HIV clinic in a semi-rural area in Gabon.
The most important finding of our study was that the use of CTX-P was associated with a
reduced prevalence of Loa loamicrofilaremia. ART use was not associated with a reduced
prevalence of helminth infections. Additional studies are needed to assess the effects of
CTX on helminth infections, as this might be a promising safe and effective drug adding to
the limited repertoire of anthelminthic drugs.
Introduction
Globally, more than 2 billion people are estimated to be infected with soil-transmitted hel-
minths, and the geographical distribution of these infections overlaps considerably with re-
gions of high HIV sero-prevalence [1,2]. Helminth infections have been hypothesized to be
factors driving the HIV-epidemic in Africa [3,4], which may be due to their effects on the host
immune system, as demonstrated by an increased susceptibility to HIV infection and progres-
sion to AIDS [3]. However, the immunological interaction between the two infections is com-
plex, and others have found results that are conflicting with this hypothesis [5].
Although treatment of intestinal helminth infections and schistosomiasis is relatively simple
and cheap, current options are limited to a few drugs, and emergence of resistance is anticipat-
ed [6,7]. Currently, no really effective and safe drug is available for the treatment of filariases.
Diethylcarbamazine (DEC) is only moderately effective and has to be administered under su-
pervision, due to its toxicity. DEC or ivermectin treatment may cause serious adverse reactions
due to microfilarial disintegration triggering a cytokine release [8]. This underscores the need
for new drugs for the treatment of helminth infections.
Data on helminth co-infections in patients receiving ART is scarce, as well as information
on possible ART effects on helminth infections. Studies investigated patients on ART and
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compared them to non-treated or HIV-negative controls, usually looking at all intestinal para-
sites [9–13]. Although the common theme is that parasite infections are reduced in patients on
ART, the underlying mechanisms remain unclear. Naturally, improved cellular immunity is
often mentioned to explain these findings [9,10], especially for protozoal infections such as
cryptosporidiosis. However, several authors speculate on the contribution of drug effects, both
from ART as well as from cotrimoxazole preventive therapy (CTX-P), on the reduction of par-
asite burden [9,11,13].
Whilst most studies were cross-sectional or used historic controls, one Ethiopian study in
patients with newly diagnosed tuberculosis found a significant reduction in helminth infections
over time only in HIV-positive as compared to HIV-negative individuals [11]. Authors specu-
late on the possible effects of ART or CTX-P to explain these findings. A cross-sectional study
in Rwanda found a reduced risk of T. trichiura infection in patients using stavudine in combi-
nation with lamivudine and nevirapine (OR, 0.27; 95% CIs, 0.10–0.76; p<0.05) compared to
those on zidovudine, lamivudine and nevirapine [14]. Unfortunately, these studies were not de-
signed to address a specific ART effect on helminth infections. Anthelminthic drugs of the
benzimidazole class appear to act on the mitochondrion, supposedly on its tubulin structure
[15]. Interestingly, mitochondrial toxicity seems to be a common adverse effect of many anti-
retroviral drugs [16], with stavudine exhibiting the highest degrees of mitochondrial toxicity
[17]. This toxic effect is mediated through multiple mitochondrial pathways including inhibi-
tion of gamma DNA polymerase [18].
Whether CTX is effective against helminths is less clear. It consists of sulfamethoxazole and
trimethoprim which interfere with folate biosynthesis and metabolism. CTX is active against
various bacteria, Pneumocystis jirovecii, several parasites, such as Toxoplasma gondii and Plas-
modium spp. [19,20], and the intestinal parasites Isospora belli and Cyclospora cayetanensis
[20].
The aims of this study were to systematically assess the prevalence of helminth infection
among HIV-patients in Lambaréné, Gabon, and to investigate whether ART or CTX-P use is
associated with a reduced risk of helminth infections. We hypothesized (i) that ART may be as-
sociated with a reduced risk of helminth infection, possibly due to mitochondrial toxicity of the
ART on the worms, and that (ii) CTX-P may reduce the risk of helminth infection through in-
tervention with the folic acid metabolism of the worms.
Materials and Methods
Study site
Between October 2012 and June 2014, a cross-sectional study was conducted in Lambaréné, a
town of 25,000 inhabitants situated within the Central African rainforest area of the Moyen
Ogooué province, Gabon. Patients were recruited at the Centre de Traitement Ambulatoire
(CTA), which is the main clinic for HIV-care in Lambaréné. At this clinic, patients were fol-
lowed up every 3 months, with an additional follow-up visit after 2 weeks if a patient was
started on ART. ART was initiated if patients had CD4 counts<350 cells/μL or were symptom-
atic (World Health Organization (WHO) stage 3 or 4 [21]). Patients received CTX-P if they
had CD4 counts<200 cells/μL, in accordance with the Gabonese national guidelines valid at
the time of the study. Cotrimoxazole was stopped after two subsequent measurements of CD4
count above 200 cells/uL. Diagnostics for intestinal parasites were not routinely done. Howev-
er, patients did receive a single dose of albendazole on a 3 monthly basis. Parasitologic diagnos-
tic procedures were performed at the Centre de Recherches Médicales de Lambaréné
(CERMEL). The study design capitalized on the limited data available; namely a prevalence of
helminth infections of 40–50% in pregnant women and 70% in school-going children [22,23].
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Filariases and schistosomiasis are endemic in the region [23,24]. S. haematobium is endemic in
Gabon, whereas S.mansoni is not. All hookworm infections are N. americanus; A. duodenale is
not endemic in the study area. HIV seroprevalence is estimated at 3.9% in Gabon [25].
Ethics statement
Ethical clearance was obtained from the Institutional Research Board of CERMEL. All adult
subjects provided written informed consent.
Study population
Any consenting HIV-infected adult (age>18 years) attending the HIV clinic was invited to
participate. Patients were divided into two groups: ART naïve, or taking ART for at least 3
months. Patients who started ART within 3 months before recruitment were excluded, to
avoid potential effects from previous ART and CTX-P on helminths. Inclusion rates and CD4
counts of patients not enrolled were documented to avoid selection bias. Sample size was calcu-
lated based on a power of 80%, and an estimated 25% difference in prevalence between respec-
tive groups. We assumed that 65% of patients in the non-exposed group would be ‘helminth-
infected’, based on available data [22–24]. The calculated sample size was 125 patients. Howev-
er, an interim analysis revealed lower helminth infection prevalences (ART naïve 32%, on ART
19%). The sample size was amended accordingly to 352 patients, with some additional patients
to compensate for patients submitting incomplete samples.
Collection of data
Basic demographic data (age, sex, salary, profession, educational level, residence, pregnancy)
were obtained and clinical data were collected using patient files (ART and CTX-P history,
WHO stage [21], history of opportunistic infections, anthelminthic treatment) and laboratory
registers from the HIV clinic (CD4 counts and hemoglobin). Three stool and urine samples
were collected on consecutive days. Where possible, patients submitted stool samples on the
day of collection. However, as many patients were living far away from the clinic, we used a
maximum time period for acceptance of samples of 24 hours. Stool samples were examined for
presence of eggs in smears prepared by the Kato Katz method [26]. Stool samples were ana-
lysed for the presence of larvae of S. stercoralis and N. americanus using the modified agar-
plate culture technique [27]. Stool was incubated at 25°C on an agar plate. The culture superna-
tant was checked for larvae with microscopy after 3 and 7 days.
Urine was filtrated and analysed for presence of eggs by microscopy. In addition, 2 mL of
blood was collected by venipuncture into EDTA around noon (11 am—1 pm). EDTA blood
was analysed by direct microscopy. In addition, red blood cells were lysed using Saponin solu-
tion, after which cells were centrifuged. The pellet was analysed for presence of microfilariae by
microscopy. If microfilariae were present, samples were stained with methylene blue to identify
Loa loa orM. perstans [28]. All positive samples were confirmed by a senior
laboratory technician.
Outcomes and variables
Outcome was helminth infection, defined as at least one positive stool, urine or blood sample
for intestinal helminths (T. trichiura, A. lumbricoides, N. americanus, S. stercoralis), S. haema-
tobium or microfilaria (Loa loa orM. perstans). Factors assessed for their association with hel-
minth infection prevalence were ART and CTX-P use. As pre-defined risk factors were
considered age, sex, educational level and rural versus urban residence. The following factors
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were considered as potential confounders: income, pregnancy, WHO stage, body mass index
(BMI), CD4 count, hemoglobin and use of anthelminthic treatment<12 weeks prior
to participation.
The outcome for the primary analysis was the diagnosis of any helminth infection. Patients
were included if they provided at least 2 stool and urine samples and one blood sample.
Secondly, sub-analyses were done for different groups of helminth infections; intestinal hel-
minths (T.trichiura, A. lumbricoides, N. americanus or S. stercoralis); S. haematobium; and the
filariae Loa loa andM. perstans. Patients were included for sub-analyses if they provided at
least 2 stool samples (intestinal helminths), 2 urine samples (S. haematobium) or 1 blood sam-
ple (filariases).
Statistical analysis
The distribution of pre-defined risk factors, potential confounders and exposure to ART or
CTX-P of patients who were diagnosed with any helminth infection were compared to those
who were not infected. We used the χ² test for categorical data, the Student’s t-test for normally
distributed continuous data and the Mann-Whitney-U test for non-normally distributed data.
Data were assessed for completeness. If for a certain factor,>10% of data were missing, pa-
tient characteristics for the group with missing data were compared to those with
complete data.
Multivariable logistic regression analysis was used to assess the odds of helminth infection
associated with the main exposures (ART and CTX-P). Odds ratios were adjusted for pre-de-
fined risk factors. Potential confounders were assessed for their interaction with the main expo-
sures (ART and CTX-P). Factors causing an odds ratio change of>10% were considered as
confounders and included in the final model, avoiding multi-collinearity. CD4 count was ex-
cluded from the primary analysis because it is a key parameter in decision-making on ART ini-
tiation. CTX-P use is inevitably linked with ART use (patients on CTX-P will as well qualify for
ART, unless ART naïve and treated for another opportunistic infection before starting ART).
Therefore, we performed a sub-group analysis including only patients on ART to assess the
odds of helminth infections associated with CTX-P exposure. In this same sub-group, the me-
dian time on ART was compared between patients diagnosed with helminth infections and
those without using the MannWhitney U test. We also included the time on ART in the multi-
variate analysis. Analyses were done using SPSS Statistics Version 21 (IBM, Chicago, IL, USA).
Results
A total of 803 patients were screened and 408 patients were recruited (Fig 1). Two-hundred
fifty-two patients submitted at least 2 stool and urine samples and one blood sample, and were
included in the main analysis.
Baseline characteristics of the study population are given in Table 1. The mean age was 41
years (standard deviation (SD) 12 yrs); the majority was female. The majority of patients lived
in a semi-urban setting, and had a highest educational level of secondary school. The median
CD4 count at the time of study participation was 356 cells/μL (interquartile range [IQR] 186–
526). Around 60% of patients had been on ART for at least 3 months. Almost half the study
population was receiving CTX-P.
For most determinants, completeness of data was>90%. However, there was>10% missing
data for hemoglobin (92/252, 36%), the self-reported use of anthelminthic treatment (101/252,
40.1%), and use of CTX-P (30/252, 11.9%). Patient characteristics for missing data are given in
S1 Table. ART use was reported less often for patients with missing data for all 3 variables.
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Patients with missing data on the use of CTX-P were more likely to have any infection and to
have an infection with intestinal helminths.
Fig 2 displays the prevalence of helminth infections. The overall prevalence was 77/252
(30.5%). Sub-analyses showed that filariases were most prevalent (56/310, 18.1%); 19/323
(5.9%) individuals were infected with S. haematobium; 35/296 (11.8%) subjects carried one or
more intestinal helminths.
Patients carrying one or more helminths were more frequently male, lived in rural areas and
were less educated (Table 1). There were no differences in income, WHO stage, pregnancy or
BMI (S2 Table).
Patient characteristics for patients infected with intestinal helminths or Loa loa versus those
not infected are given in S3 Table. Patients diagnosed with intestinal helminths were more
often living in rural areas as compared to those with no diagnosis of intestinal helminths. Loa
loa, the most prevalent infection in this cohort, was found more frequently in male patients,
and ART and CTX-P use were reported more often in the non-infected patient group.
In multivariable logistic regression, there was no evidence of an association between ART
use and the risk of having any infection, infection with intestinal helminths, or Loa loa
(Table 2). In contrast, CTX-P was associated with a reduced risk of Loa loamicrofilaremia, in
the whole population as well as in the subgroup analysis of patients on ART. Female sex was as-
sociated with a 3-fold decreased risk of any infection and loiasis. Lower education level was as-
sociated with a 2.5-fold increased risk of having any infection, and rural residence was
Fig 1. Study flow. Study flow displaying the inclusion of study participants. Patients were included in the
main analysis if they provided at least 2 stool and urine samples and one blood sample. Patients were
included for subanalyses if they provided at least 2 stool samples (intestinal helminths), 2 urine samples (S.
haematobium) or 1 blood sample (filariases).
doi:10.1371/journal.pntd.0003769.g001
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associated with an almost 4-fold increased risk of infection with one or more intestinal hel-
minths. There was no evidence of an association between time on ART and the risk of having
any infection, infection with intestinal helminths, or Loa loa (Table 2). Also, there was no dif-
ference in median time on ART of patients diagnosed with one or more helminth infections
compared to those not infected (S4 Table).
Discussion
This study assessed the prevalence of helminth infections in HIV-infected adults in Lambaréné,
Gabon, and the association of ART and CTX-P with the prevalence of helminth infections.
ART use did not alter the risk of harbouring any of the studied infections; intestinal helminths
(T. trichiura, A. lumbricoides, N. americanus, S. stercoralis), S. haematobium, or microfilaria
(Loa loa,M. perstans). In contrast, CPT use reduced the risk of Loa loamicrofilaremia. The
overall infection prevalence was 30.5%, which compares favorably to earlier studies in the same
region [22–24], yet is well in line with similar studies from other settings [9–13]. The recruit-
ment of individuals who may have a different risk for helminth infections, like pregnant
Table 1. Patient characteristics.
Dataa (n) Total cohort Not infected Any infection P-valueb
Age; years (mean, SDc) 250 41.9 (12.0) 42.6 (12.4) 40.3 (10.9) 0.18
Sex (female)(n, %) 252 169 (67.1) 127 (72.6) 42 (54.5) 0.005
Residence (n,%) 249 0.004
- Rural 76 (30.5) 43 (24.7) 44.0)
- Semi-urban 148 (59.4) 111 (63.8) 49.3)
- Urban 25 (10.0) 20 (11.5) 5 (6.7)
Educational level (n, %) 243 0.07
- Lower than primary 23 (9.5) 15 (8.9) (10.8)
- Primary 66 (27.2) 40 (23.7) 35.1)
- Secondary 8.3) 108 (63.9) 52.7)
- Tertiary/higher 7 (2.8) 6 (3.6) 1 (1.4)
CD4 count; cells/μL (median, IQRd) 247 366 (177–555) 345(159–531) 382(185–579) 0.85
CD4 count stratified (n,%) 0.99
- 0–100 cells/μL 36 (14.6) 21 (12.4) 19.5)
- 101–200 cells/μL 33 (13.4) 27 (15.9) (7.8)
- 201–350 cells/μL 51 (20.6) 38 (22.4) 16.9)
- >351 cells/μL 127 (51.4) 84 (49.4) 43 (55.8)
Hemoglobin; g/dL (median, IQRd) 160 10.0 (10.0–12.0) 11.0 (10.0–12.0) 11.7 (10.7–12.7) 0.07
On ARTe >12 weeks (n, %) 252 149 (59.1) 111 (63.4) 38 (49.4) 0.04
On CTX-Pf (n, %) 222 103 (46.4) 76 (47.8) 27 (42.9) 0.51
Antihelminth treatment <12 weeks (n, %) 151 53 (35.1) 38 (36.5) 15 (31.9) 0.58
Characteristics of those patients who were diagnosed with one or more helminth infections versus those who had negative test results.
aThe first column shows for how many patients data were complete for each respective variable.
b P-values were calculated using the χ² test was used for categorical variables (ordinal χ² test if more than 2 categories), the Students' T test for linear
normally distributed variables, and Mann Whitney U for non-parametric variables.
c Standard deviation (SD),
d Interquartile range (IQR),
eAnti-retroviral therapy (ART),
f Cotrimoxazole preventive therapy (CTX-P).
doi:10.1371/journal.pntd.0003769.t001
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women or school children, hampered direct study comparisons. Furthermore, many studies in-
vestigated only intestinal parasites but included protozoa [9–14]. In this study, systemic hel-
minth infections were also investigated, with filarial infections being most prevalent (18.1%)
followed by S. haematobium (5.9%). Intestinal helminth infections were found in only 11.8%,
in line with infection rates observed in other studies [13,14]. However, higher rates for A. lum-
bricoides and S. stercoralis have been reported, especially in the pre-ART era [9].
This study found microfilaremia more frequently in males. This finding is not new [24,29].
One possible explanation is behavioral factors, such as male patients working in the forest and
therefore being more exposed during day time [24,29]. Animal models have shown potential
effects of gonadal hormones [30]. Rural residence is a known risk factor for helminth infection
[31,32] and was associated with infections in this study. In general, factors associated with pov-
erty are associated with an increased risk for helminth infection [31,32].
CD4 counts were not correlated with the risk of harboring helminth infections. No signifi-
cant difference in CD4 count distribution was observed between helminth-infected and unin-
fected patients (Table 1). Only one hyper-infection syndrome with S. stercoralis was
encountered in a HTLV-1 co-infected patient [33]. Data on the interplay of immune depres-
sion due to HIV and helminth infections are conflicting. A recent study reported higher co-in-
fection risk with higher CD4 counts [31]. In agreement with this, a negative association of CD4
counts and risk of helminth infection was reported in HIV-infected patients in Uganda [34].
However, conflicting data have been reported from other settings [32]. None of these studies
Fig 2. Prevalence of helminth infections. The prevalence of helminth infections is displayed for all infections together, as well as the subgroups intestinal
helminth infections and filariases, and for each individual infection.
doi:10.1371/journal.pntd.0003769.g002
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documented CTX-P as a potential confounder or causal factor for the altered prevalence of hel-
minth infection in patients with lower CD4 counts.
Although several studies addressed the effect of deworming on HIV viral load and CD4
counts as reviewed elsewhere [35,36], little is known about the opposite effect of HIV-related
treatments such as ART and CTX-P on helminths. In this study, ART use did not alter the risk
of any helminth infections. However, although ART was not associated with a risk reduction of
helminth infections when adjusted to pre-defined risk factors and confounders, the rather low
number of infections may have masked a more discrete effect. In contrast, CTX-P reduced the
risk of Loa loamicrofilaremia in the whole population as well as in the subgroup of patients on
ART (Table 2).
Antifilarial effects of dihydrofolate reductase (DHFR) inhibitors seem to exist for lymphatic
filariae [37], but no data are available for Loa loa andM. perstans. The present study suggests
CTX-P may have antifilarial effects on Loa loamicrofilaria, most likely by acting as a DHFR in-
hibitor thereby inducing apoptosis of the microfilaria [37,38]. The low number of cases ofM.
perstans and S. haematobium infection did not allow assessment of this association, and further
exploration seems warranted. CTX-P might be a safer alternative compared to the currently
available agents, DEC and ivermectin, either as curative agent, or used for reducing worm bur-
den prior to administration of one of the classical drugs to reduce the risk of adverse reactions.
Table 2. Effect of exposure to ART or CTX-P on helminth infection prevalence.
Any infection Intestinal helminths Loa loa
Whole study population aOR 95% CI P-value aOR 95% CI P-value aOR 95% CI P-value
ARTa 0.88 0.45–1.73 0.71 0.67 0.27–1.61 0.37 0.56 0.29–1.11 0.10
Sex1 0.26 0.12–0.55 <0.001 0.60 0.22–1.61 0.31 0.33 0.16–0.69 0.003
Age2 0.64 0.27–0.87 0.005 0.76 0.51–1.12 0.16 0.80 0.60–1.08 0.15
Educational level3 2.39 1.18–4.85 0.02 2.05 0.80–5.28 0.14 1.41 0.67–2.94 0.36
Residence4 2.04 1.03–4.03 0.04 3.65 1.48–8.98 0.005 1.63 0.81–3.31 0.17
CTX-Pb 0.78 0.41–1.73 0.71 0.47 0.29–1.19 0.11 0.47 0.23–0.97 0.04
Subgroup on ARTa
CTX-Pb 1.04 0.44–2.52 0.91 0.75 0.22–2.54 0.64 0.34 0.12–0.92 0.03
Sex1 0.29 0.10–0.80 0.02 1.05 0.25–4.30 0.94 0.18 0.06–0.56 0.003
Age2 0.63 0.40–0.98 0.04 0.96 0.50–1.82 0.89 0.70 0.43–1.13 0.14
Educational level3 3.18 1.24–8.13 0.02 2.48 0.71–8.63 0.15 2.42 0.85–6.94 0.10
Residence4 1.41 0.56–3.52 0.46 5.68 1.54–20.9 0.009 0.64 0.22–1.85 0.41
CD4 count 5 1.01 0.92–1.10 0.84 0.89 0.77–1.04 0.15 1.08 0.98–1.19 0.11
Time on ART6a 1.01 1.00–1.03 0.15 1.00 0.97–1.02 0.88 0.99 0.97–1.01 0.31
Multivariable logistic regression analysis was used to assess the odds of helminth infections associated with the main exposures (ART and CTX-P). Odds
ratios were adjusted for pre-defined risk factors. Potential confounders were assessed for their interaction with the main exposures (ART and CTX-P).
Factors causing an odds ratio change of >10% were considered as confounders and included in the final model, avoiding multi-collinearity.
1Female versus male sex,
2age per 10 years increase,
3 primary school or lower versus secondary school or higher,
4rural residence versus (semi-)urban,
5 CD4 count per 50 cells/μL increase,
6time on ART in months,
aAnti-retroviral therapy (ART),
b Cotrimoxazole preventive therapy (CTX-P)
doi:10.1371/journal.pntd.0003769.t002
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Interestingly, a potentially reduced risk of infection with intestinal helminths in patients re-
ceiving CTX-P was not observed. One explanation could be the lower trimethoprim affinity to
intestinal helminths’DHFR, while lower bioavailability and drug concentrations at the site of
intestinal worm infection may be alternative explanations. In fact, CTX is very well absorbed
and mainly excreted in urine [39] and thus levels in the gut may be too low to be effective
against helminths. However, CTX is used successfully to treat several intestinal infections,
caused by bacteria and protozoa. They might be more sensitive even to lower concentrations,
considering that their DHFR has a much higher affinity to trimethoprim than
intestinal helminths.
This study has several strengths. To increase specificity of the parasitologic diagnosis, at
least 2 negative stool or urine samples were necessary to qualify as a negative test result. The Sa-
ponin method for detection of microfilariae has been found superior to a thick blood smear
[40]. However, the absence of microfilaraemia does not exclude infection with Loa loa orM.
perstans. Previously reported risk factors were found also in this study, thereby assuring the ex-
ternal validity of the data reported.
However, there are also limitations. Although recommended by the WHO, the sensitivity of
the Kato-Katz method is not optimal [41]. The modified agar-plate culture method is relatively
sensitive for detection of S. stercoralis larvae, but less so for hookworm larvae [42]. It should be
noted that not all studies use the same methodology for the detection of parasites in stools,
which may make direct comparisons difficult, especially at low concentrations of eggs. By
using more sensitive methods, possibly more cases could have been identified, although it ap-
pears doubtful that this would have changed the overall results. Secondly, not all patients sub-
mitted sufficient samples to be included in the final analysis. Therefore, the statistical power to
detect certain associations was lower than expected even though the calculated sample size was
reached. The use of anthelminthic treatment was not directly observed and self-reported data
available on its use during the 12 weeks prior to study participation were limited. There was no
clearly reduced infection prevalence in patients who reported prior anthelminthic treatment.
This could be explained by the fact that the anthelminthic treatment which was administered
at the time of the study was single-dose albendazole, of which the efficacy has been shown to be
limited in this setting [43]. Recall bias may have played a role in data availability on self-re-
ported anthelminthic treatment. Prevalences of helminth infections did not differ among pa-
tients with incomplete data on the use of antihelminth treatment versus those with complete
data, although they were more likely to have certain risk factors for infection (S1 Table).
Drugs with less mitochondrial toxicity might have been used in the treatment scheme, thus
masking any anti-helminthic effect of ART based on mitochondrial toxicity. The design of this
study did not permit assessment of associations of helminth infection with different antiretro-
viral drugs. In the absence of randomisation between treatment regimens, analyses of treat-
ment effects in observational data are possible using causal methods such as inverse probability
weighting, for which our sample was too small. Also, we did not collect data on compliance to
ART and cotrimoxazole. Lack of compliance in certain patient groups may have masked anti-
helminthic effects of both ART and cotrimoxazole. There were no reliable data available on the
duration of CTX-P. Therefore a sensitivity analysis of the effect of the duration of CTX-P on
the risk of helminth infections was not possible.
In conclusion, the main findings of this study are a high prevalence of Loa loamicrofilare-
mia in HIV-patients in Gabon, and a decreased risk of Loa loa infection in patients using
CTX-P, suggesting an anthelminthic effect of antifolate drugs. No association of ART use and
helminth infections was established. Additional studies are needed to further assess the effects
of CTX on blood-dwelling microfilariae and other helminths, as this might be a safe, cheap and
effective alternative to (few) existing treatment options.
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